Laurent Debarbieux

Associate Professor

Institut Pasteur

France

Research Interests

Explore related searches

Professors in France Professors in Microbiology Microbiology professors in France

Contact this professor

ORCID

Google Scholar

About

Laurent Debarbieux is an Associate Professor at Institut Pasteur in France. His research focuses on phage therapy, bacteriophage interactions, and the genetic characterization of phages, particularly in relation to antibiotic-resistant infections. His recent articles explore topics such as phage host range, the dynamics of phage therapy in lung infections, and the implications of bacteriophage resistance in Escherichia coli. He is actively involved in advancing the understanding of phage collections and their applications in healthcare.

Laurent Debarbieux

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Phages with a broad host range are common across ecosystems

Isolation and characterization of Acinetobacter phage vAbaIN10 active against carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from healthcare-associated infections in Dakar, Senegal

“French Phage Network” annual conference—eighth meeting report

Stable coexistence between an archaeal virus and the dominant methanogen of the human gut

Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections

Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection

Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy

Complete genome sequences of two Klebsiella pneumoniae phages from Dakar, Senegal

High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off Method

Prediction of strain level phage–host interactions across the Escherichia genus using only genomic information

Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate

The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy

The role of the animal host in the management of bacteriophage resistance during phage therapy

Repetitive Exposure to Bacteriophage Cocktails against <i>Pseudomonas aeruginosa</i> or <i>Escherichia coli</i> Provokes Marginal Humoral Immunity in Naïve Mice

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination.

Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy

Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy

The intestinal virome: lessons from animal models

Viral Host Range database, an online tool for recording, analyzing and disseminating virus–host interactions

Prophylactic Administration of a Bacteriophage Cocktail Is Safe and Effective in Reducing Salmonella enterica Serovar Typhimurium Burden in Vivo

Collaborators (13)

Chantal Viola Weißfuß

Geraldine Nouailles

Nika Pende

Dwayne R. Roach

Florian Tesson

jean-damien ricard

Aude A Ferran

Karine Labadie

Nicolas DUFOUR

Pascal Hersen

François Javaudin

Claas Kirchhelle

Luisa De Sordi

How do I reach out?

Meet Kite AI